Impact of the use of immunoglobulin palivizumab in the State of São Paulo: a cohort study
ABSTRACT Introduction: the use of palivizumab as prophylaxis of the respiratory syncytial virus is not a consensus. In Brazil, it is a public health program, but other countries do not consider it cost-effective. Objective: to identify the rate of hospitalization in Intensive Care Unit for respira...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2017-09-01
|
Series: | Revista Latino-Americana de Enfermagem |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692017000100371&lng=en&tlng=en |